Germ Cell Tumor of the Yolk Sac in the Uterine Corpus: Case Report of a 14-Month-Old Female Infant.
| Autor: | Suárez A Sr; Pediatric Oncology, Instituto Nacional de Cancerología, Bogotá, COL., Brito Moreno J; Pediatric Hematology and Oncology, Instituto Nacional de Cancerología, Bogotá, COL., Suaza Vallejo MC; Pediatric Oncology, Instituto Nacional de Cancerología, Bogotá, COL., Luengas JP; Pediatric Oncology, Instituto Nacional de Cancerología, Bogotá, COL., Blanco C; Pediatric Oncology, Instituto Nacional de Cancerología, Bogotá, COL. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Dec 18; Vol. 15 (12), pp. e50737. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.50737 |
| Abstrakt: | Malignant germ cell tumors (MGCTs) localized in the uterus are rare in prepubertal girls. They typically occur in postmenopausal women and are characterized by the presence of a pelvic mass and transvaginal bleeding. In this case, the authors describe the clinical features, radiologic findings, histopathologic description, and treatment received by an infant with a primary yolk sac tumor of the uterine wall. Currently, treatment for uterine GCTs is based on guidelines for GCTs. Surgery and bleomycin, etoposide, cisplatin (pBEP) chemotherapy are effective for uterine yolk sac tumors. After 46 months of clinical follow-up, which included abdominopelvic ultrasound and tumor marker assessments, our patient is free of disease, suggesting a favorable outcome. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Suárez et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|